Additionally, this can aggravate IR by inhibiting insulin signal transduction and reducing insulin clearance, forming a vicious cycle and, ultimately, influencing lipid metabolism and inducing NAFLD progression [34]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.